Peer-reviewedLicence not statedAutoimmunity Reviews
Drugs associated with systemic sclerosis: An updated list of suspected drugs using the WHO pharmacovigilance database
Related
- Comparative real-world pharmacovigilance analysis of adverse event signals associated with six approved CAR-T products using the FAERS database.
- Donor-Resolved Analysis of HES1-Associated Fibroblast States in Systemic Sclerosis
- Sotatercept-related peripheral microvascular alterations in systemic sclerosis–associated pulmonary arterial hypertension: insights from nailfold capillaroscopy
- Adverse drug events associated with hydroxychloroquine : A real-world pharmacovigilance study from 2004 to 2024 using the FAERS database
- Scleroderma Renal Crisis-Associated Thrombotic Microangiopathy Preceding Skin Sclerosis in Diffuse Cutaneous Systemic Sclerosis: A Case Report
BibTeX
@article{dumont2026drugs,
title = {{Drugs associated with systemic sclerosis: An updated list of suspected drugs using the WHO pharmacovigilance database}},
author = {Anaël Dumont and Charles Dolladille and Hubert de Boysson and Joachim Alexandre and Alexandre Nguyen and Samuel Deshayes and Achille Aouba},
journal = {Autoimmunity Reviews},
year = {2026},
month = sep,
doi = {10.1016/j.autrev.2022.103157},
url = {https://hal.science/hal-05743395v1},
}
RIS
TY - JOUR
TI - Drugs associated with systemic sclerosis: An updated list of suspected drugs using the WHO pharmacovigilance database
AU - Anaël Dumont
AU - Charles Dolladille
AU - Hubert de Boysson
AU - Joachim Alexandre
AU - Alexandre Nguyen
AU - Samuel Deshayes
AU - Achille Aouba
PY - 2026
DA - 2026/09/09
JO - Autoimmunity Reviews
DO - 10.1016/j.autrev.2022.103157
UR - https://hal.science/hal-05743395v1
SN - 1568-9972
SN - 1873-0183
ER -